Femasys (FEMY) Capital Expenditures Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 9.65% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 61.83% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -63.39% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 14.32% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 21.73% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 12.30% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 15.01% |
| 10 | Femasys | 22.30 Mn | 16.91 Mn | - | -18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.08% |
| Dec 31, 2025 | 30.95% |
| Sep 30, 2025 | -52.36% |
| Jun 30, 2025 | -48.35% |
| Mar 31, 2025 | 49.64% |
| Dec 31, 2024 | 137.85% |
| Sep 30, 2024 | 1,401.48% |
| Jun 30, 2024 | 189.80% |
| Mar 31, 2024 | 625.28% |
| Dec 31, 2023 | -52.17% |
| Sep 30, 2023 | 46.54% |
| Jun 30, 2023 | -63.97% |
| Mar 31, 2023 | -92.61% |
| Dec 31, 2022 | -20.86% |
| Sep 30, 2022 | -89.45% |
| Jun 30, 2022 | 1,296.18% |
| Sep 30, 2021 | 5,222.02% |